CLINICAL TRIALS PROFILE FOR MONTELUKAST SODIUM
✉ Email this page to a colleague
All Clinical Trials for Montelukast Sodium
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00000577 ↗ | Asthma Clinical Research Network (ACRN) | Withdrawn | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 1993-09-01 | This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma. |
NCT00000577 ↗ | Asthma Clinical Research Network (ACRN) | Withdrawn | Milton S. Hershey Medical Center | Phase 3 | 1993-09-01 | This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma. |
NCT00076973 ↗ | An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2003-08-01 | The purpose of this study is to look at whether an investigational drug can treat the breathing symptoms of RSV bronchiolitis in children 3 to 24 months of age. |
NCT00092105 ↗ | Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2002-04-01 | The purpose of this study is to determine the protective effect of an approved medication on asthma and allergic rhinitis (inflammation of the mucous membrane of the nose) upon exposure to cats. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Montelukast Sodium
Condition Name
Clinical Trial Locations for Montelukast Sodium
Trials by Country
Clinical Trial Progress for Montelukast Sodium
Clinical Trial Phase
Clinical Trial Sponsors for Montelukast Sodium
Sponsor Name